文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症患者自我拔管:来自法国OUTCOMEREA网络的研究

Self-extubation in critically ill patients: from the French OUTCOMEREA Network.
PubMed 文献 · Crit Care · 2025-07-07
一句话结论自我拔管后48小时内再插管与28天死亡率(HR 3.03)和90天死亡率(HR 2.86)升高独立相关,肠内营养、机械通气>7天、非神经SOFA评分较高与再插管独立相关,自我拔管后24小时内使用无创通气与再插管独立相关(OR 0.28)。

该研究基于法国ICU数据库OutcomeRea™,纳入1996年11月至2022年5月期间12,917例ICU插管患者中的701例发生自我拔管且当时无治疗限制的患者,其中276例(39.4%)需要再插管。调整分析显示,自我拔管前一天较高的非神经SOFA评分(OR 1.16)、自我拔管前有创机械通气>7天(OR 1.79)、自我拔管当天肠内营养(OR 2.59)与再插管独立相关,而自我拔管后24小时内使用无创通气(OR 0.28)与再插管独立相关。自我拔管后48小时内再插管与28天死亡率(HR 3.03)、90天死亡率(HR 2.86)、院内肺炎风险(sdHR 18.28)及ICU住院时间延长13天独立相关。

要点

  • 自我拔管后48小时内再插管与28天死亡率升高独立相关(HR 3.03 [1.79; 5.12]),与90天死亡率升高独立相关(HR 2.86 [1.86; 4.4])。
  • 自我拔管当天肠内营养与再插管独立相关(OR 2.59 [1.75; 3.84]),自我拔管前有创机械通气>7天与再插管独立相关(OR 1.79 [1.04; 3.26])。
  • 自我拔管前一天非神经SOFA评分较高与再插管独立相关(OR 1.16 [1.01; 1.34])。
  • 自我拔管后24小时内使用无创通气与再插管独立相关(OR 0.28 [0.16; 0.5])。
  • 自我拔管后48小时内再插管与院内肺炎风险升高独立相关(sdHR 18.28 [7.70; 43.42]),与ICU住院时间延长13天相关(p < 0.01)。

适用人群与场景

  • 法国ICU数据库OutcomeRea™中1996年11月至2022年5月期间ICU插管患者。
  • 发生自我拔管且当时无治疗限制的患者,共701例。

研究设计与关键结果

  • 研究类型为基于法国ICU数据库OutcomeRea™的分析,纳入12,917例ICU插管患者中701例发生自我拔管且当时无治疗限制的患者,其中276例(39.4%)需要再插管。
  • 调整分析显示,自我拔管前一天非神经SOFA评分较高与再插管独立相关(OR 1.16 [1.01; 1.34];p = 0.03)。
  • 自我拔管前有创机械通气>7天与再插管独立相关(OR 1.79 [1.04; 3.26];p = 0.04)。
  • 自我拔管当天肠内营养与再插管独立相关(OR 2.59 [1.75; 3.84];p < 0.01)。
  • 自我拔管后24小时内使用无创通气与再插管独立相关(OR 0.28 [0.16; 0.5];p < 0.01)。
  • 自我拔管后48小时内再插管与28天死亡率升高独立相关(HR 3.03 [1.79; 5.12];p < 0.01),与90天死亡率升高独立相关(HR 2.86 [1.86; 4.4];p < 0.01)。
  • 自我拔管后48小时内再插管与院内肺炎风险升高独立相关(sdHR 18.28 [7.70; 43.42];p < 0.01),与ICU住院时间延长13天相关(p < 0.01)。

证据类型、等级与局限

  • 证据类型:基于法国ICU数据库OutcomeRea™的分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于自我拔管后24小时内使用无创通气的患者,研究显示其与再插管风险降低独立相关(OR 0.28 [0.16; 0.5])。
  • 对于自我拔管当天接受肠内营养、自我拔管前有创机械通气>7天或自我拔管前一天非神经SOFA评分较高的患者,研究显示其与再插管风险升高独立相关。
  • 自我拔管后48小时内再插管与28天死亡率、90天死亡率、院内肺炎风险和ICU住院时间延长独立相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Self-extubation is a common complication in intubated patients in the intensive care unit (ICU) and is associated with a high rate of reintubation. This study aimed to identify predictors of reintubation following self-extubation (SE) and assess the prognosis of these patients.

METHODS: Data were extracted from the French ICU database, OutcomeRea™. The primary objective was to identify factors associated with reintubation within 48 h after self-extubation. Secondary objectives included evaluating the association between reintubation and mortality, ICU length of stay, and nosocomial pneumonia.

RESULTS: Between November 1996 and May 2022, 12,917 patients were intubated in the ICU. Among them, 701 patients experienced SE without therapeutic limitations at the time, and 276 (39.4%) required reintubation. In adjusted analyses, the following factors were independently associated with reintubation: a higher non-neurological SOFA score on the day before SE (OR 1.16 [1.01; 1.34]; p = 0.03), duration of invasive mechanical ventilation > 7 days before SE (OR 1.79 [1.04; 3.26]; p = 0.04), enteral nutrition on the day of SE (OR 2.59 [1.75; 3.84]; p < 0.01) and the use of non-invasive ventilation (NIV) within 24 h after SE (OR 0.28 [0.16; 0.5];p < 0.01). Reintubation within 48 h after SE was independently associated with increased 28-day mortality (HR = 3.03 [1.79; 5.12]; p < 0.01) and 90-day mortality (HR = 2.86 [1.86; 4.4]; p < 0.01), a higher risk of nosocomial pneumonia (sdHR, 18.28 [7.70; 43.42]; p < 0.01), and a 13-day increase in ICU length of stay (p < 0.01).

CONCLUSION: Enteral nutrition on the day of SE, prolonged mechanical ventilation prior to SE, higher non-neurological SOFA scores, and use of NIV after SE were independently associated with the need for reintubation. Reintubation was also associated with increased mortality, a higher risk of nosocomial pneumonia, and prolonged ICU stay.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Trenchat L, Galerneau LM, Ruckly S, et al. Self-extubation in critically ill patients: from the French OUTCOMEREA Network. Crit Care. 2025. PMID: 40624565. doi:10.1186/s13054-025-05472-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。